REPARE THERAPEUTICS INC's ticker is RPTX and the CUSIP is 760273102. A total of 75 filers reported holding REPARE THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.06 and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $19,809,376 | +14.2% | 1,639,849 | 0.0% | 5.29% | +51.3% |
| Q2 2023 | $17,349,602 | +7.5% | 1,639,849 | 0.0% | 3.49% | -16.7% |
| Q1 2023 | $16,136,114 | -33.1% | 1,639,849 | 0.0% | 4.19% | -33.0% |
| Q4 2022 | $24,122,179 | +21.3% | 1,639,849 | 0.0% | 6.26% | +32.8% |
| Q3 2022 | $19,891,000 | -13.3% | 1,639,849 | 0.0% | 4.71% | -26.1% |
| Q2 2022 | $22,941,000 | -1.8% | 1,639,849 | 0.0% | 6.37% | +1.7% |
| Q1 2022 | $23,351,000 | -32.5% | 1,639,849 | 0.0% | 6.27% | -0.6% |
| Q4 2021 | $34,584,000 | -19.6% | 1,639,849 | 0.0% | 6.30% | -5.5% |
| Q3 2021 | $43,030,000 | -17.7% | 1,639,849 | -2.2% | 6.68% | -22.2% |
| Q2 2021 | $52,260,000 | -17.7% | 1,676,087 | -19.0% | 8.58% | +7.6% |
| Q1 2021 | $63,521,000 | -61.2% | 2,069,749 | -56.7% | 7.98% | -43.6% |
| Q4 2020 | $163,840,000 | +122.9% | 4,776,674 | +100.0% | 14.15% | -20.1% |
| Q3 2020 | $73,489,000 | -0.8% | 2,388,337 | 0.0% | 17.71% | -10.1% |
| Q2 2020 | $74,086,000 | – | 2,388,337 | – | 19.70% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MPM ASSET MANAGEMENT LLC | 2,242,636 | $32,989,176 | 13.80% |
| CHI Advisors LLC | 2,800,126 | $41,189,854 | 10.97% |
| MPM BioImpact LLC | 1,639,849 | $24,122,179 | 6.26% |
| BVF INC/IL | 8,291,988 | $121,975,143 | 5.15% |
| Deep Track Capital, LP | 2,727,606 | $40,123,084 | 1.68% |
| Redmile Group, LLC | 2,684,396 | $39,487,465 | 1.62% |
| HighVista Strategies LLC | 164,890 | $2,425,532 | 1.44% |
| Orbimed Advisors | 3,322,488 | $48,873,798 | 0.94% |
| Artal Group S.A. | 700,000 | $10,297 | 0.58% |
| HARBOR CAPITAL ADVISORS, INC. | 34,572 | $508,554 | 0.49% |